{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Rigel Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"RIGL"},"Address":{"label":"Address","value":"611 GATEWAY BOULEVARD,SUITE 900 SUITE 900, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 624-1100"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit https://www.rigel.com/."},"CompanyUrl":{"label":"Company Url","value":"https://www.rigel.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Esteban S. Masuda","title":"Executive Vice President-Research"},{"name":"Lisa Rojkjaer","title":"Chief Medical Officer & Executive Vice President"},{"name":"Raul R. Rodriguez","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}